Seed

Seed (operating at seed.com) is a microbiome science company pioneering applications of microbes for human and planetary health. Founded by Ara Katz and headquartered in Los Angeles, CA, Seed redefines probiotic solutions by developing clinically studied synbiotics—combining probiotics and prebiotics—to address gut health challenges. Unlike traditional probiotics, Seed’s DS-01® Daily Synbiotic leverages a 24-strain formulation backed by the largest clinical trial of its kind, targeting regularity, bloating, and gas relief. Underpinning the product is rigorous microbiome research, including SeedLabs’ environmental initiatives, which explore microbial solutions for sustainability. This empowers consumers to proactively enhance digestive wellness with science-backed precision. While funding details remain undisclosed, the company’s growth trajectory has positioned it as a notable player in the biotech space, collaborating with academic institutions to expand its impact.